Gladium

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Gladium

Gladium: Defining the Drug and Its Class

Property Description
Active ingredient Sildenafil (as Sildenafil citrate)
Form Film-coated tablet
Pharmacological class Selective PDE5 Inhibitor
Origin Synthetic compound

Gladium is a prescription-only, single-ingredient oral medication defined by its active compound, sildenafil, which is present as the citrate salt. It belongs to the precise pharmacological category of Selective Phosphodiesterase Type 5 (PDE5) Inhibitors. This classification is defined by a specific enzyme inhibitor mechanism that acts on certain tissues. This means Gladium is a synthetic compound designed for highly targeted action within the body's vascular system, an approach clinically recognized for its efficiency in modulating specific physiological pathways.


Composition, Form, and General Purpose

Gladium is supplied for oral therapy primarily as a film-coated tablet, a solid preparation consisting of the active ingredient, sildenafil, alongside necessary solid oral excipients. The tablet formulation is a key feature, favoring ease of use and standardized absorption. As a monotherapy, its high-level purpose is to support and facilitate enhanced localized blood circulation in specific arterial beds. The medication achieves this general benefit by maintaining and strengthening the natural signals that instruct the arterial smooth muscles to relax, a process known as vasodilation. This mechanism effectively aids in counteracting physiological states where restricted blood flow is a limiting factor for functional performance, a therapeutic function that remains a focus of pharmacological study.

What side effects are possible with Gladium?

Possible Side Effects and Safety Information

The official safety profile for Gladium (sildenafil) outlines potential adverse reactions categorized by frequency, reflecting data from clinical trials and post-marketing surveillance. The effects are generally related to the medicine's vasodilatory action, causing transient changes across several physiological systems.


Frequency-Classified Adverse Reactions

Adverse reactions are documented according to regulatory frequency standards:

  • Very Common (affecting ge 1 in 10 people): Headache, Flushing.
  • Common (affecting ge 1 in 100 people): Dizziness, Visual color distortion, Blurred vision, Dyspepsia (indigestion), and Nasal congestion.

These effects are typically described as transient and mild-to-moderate. The incidence of adverse events is officially documented as generally dose-related, increasing with higher amounts of the medicine.


Serious Adverse Reactions and Safety Constraints

Regulatory documentation highlights serious, though rare, post-marketing events, including Priapism (a prolonged erection lasting more than four hours), sudden decrease or loss of vision (sometimes linked to NAION), and sudden decrease or loss of hearing.

The official label mandates specific safety restrictions. Gladium is contraindicated for use with any form of organic nitrates or nitric oxide donors due to the high risk of severe hypotension. Use is also contraindicated with guanylate cyclase stimulators and in patients with certain conditions like severe hepatic impairment or a recent history of stroke or myocardial infarction. Special safety considerations are noted for patients predisposed to Priapism, such as those with sickle cell anaemia or multiple myeloma.

Overdose and Emergency Response

Overdose and When to Seek Help

Overexposure to Gladium is officially defined as the exaggeration of known adverse effects and requires immediate emergency action.

Documented Manifestations and Actions

Key Component Official Regulatory Statement
Documented Overdose Presentations Overexposure results in the increased incidence and severity of known adverse reactions. Symptoms documented in cases of overexposure include headache, flushing, dyspepsia, dizziness, and visual disturbances (e.g., color-tinge to vision).
Physiological Systems Affected The primary concern is the vascular system, with the potential for clinically significant hypotension (low blood pressure) due to the drug’s exaggerated vasodilatory effects.
Immediate Medical Action Required Patients are mandated to seek immediate medical attention or contact emergency services immediately if overexposure is suspected, regardless of symptom severity.

Overdose Management Profile

  • Antidote Status: Regulatory labeling states that no specific antidote is known for Gladium overdosage.
  • Management: Treatment is strictly confined to symptomatic treatment and supportive measures, including the monitoring of vital signs and overall clinical status.
  • Clearance: Due to the drug's high binding to plasma proteins, regulatory documents specify that renal dialysis is not expected to be an effective measure for clearance.

Connection to the Overall Overdose Profile

The official overdose profile dictates that urgent medical help must be sought because overexposure presents a risk of severe hypotension and related cardiovascular compromise. Since the body must clear the compound naturally, management is limited to supportive care and observation until clinical stability is achieved, as no specific pharmacological reversal agent is available.

Therapeutic Uses of Gladium

What Gladium Treats: Main Uses and Benefits

Gladium is commonly used to help with the management of Type 2 diabetes, a chronic condition presenting with persistently high blood sugar levels, or hyperglycemia. The medication plays a role in addressing the underlying systemic imbalance by helping to reduce and stabilize glucose levels. This therapeutic approach is considered clinically relevant for reducing the risk of long-term damage.

The common indications for Gladium involve supporting the goal of glycemic control and addressing symptom clusters that create noticeable physiological strain, such as excessive thirst, frequent urination, and feelings of persistent fatigue. By assisting with more consistent blood sugar management, the medication helps ease these discomforts and supports the patient during episodes of heightened symptoms.

“Achieving consistent glycemic control is considered relevant for reducing the risk of microvascular complications that affect sensitive organs like the nerves, eyes, and kidneys.”


Quick Fact: Relief for Systemic Imbalance

The medication generally assists with maintaining functional stability over time. Gladium supports this by contributing to the long-term management of chronic hyperglycemia, which helps patients cope more steadily with symptom fluctuations and contributes to improved day-to-day comfort.

Eligibility and Restrictions for Use

Who can and cannot use Gladium?

Eligibility for Gladium, which contains Sildenafil, is strictly defined by regulatory authorities based on absolute contraindications and patient-specific risk factors.

Contraindicated Populations (Must Not Use)

Gladium is absolutely prohibited for use in patients taking any form of organic nitrates (such as nitroglycerin) or certain soluble guanylate cyclase (sGC) stimulators (e.g., riociguat). Use is also contraindicated if a patient has a known hypersensitivity to sildenafil or any component of the tablet. Additionally, use may be restricted for patients who have experienced a stroke or myocardial infarction within the last six months, according to some official labeling.

Restrictions and Special Populations

Population Group Regulatory Status
Pediatric Patients Not established or not recommended for most uses; strictly prohibited under 1 year of age.
Severe Organ Impairment Requires caution or dose adjustment in cases of severe renal impairment and hepatic impairment.
Cardiovascular Risk Requires caution in cases of resting hypotension or specific cardiovascular conditions predisposing to risk.

Official documents state that there are no adequate, well-controlled studies on the use of Gladium during pregnancy, and the active substance is excreted in human breast milk.

What should I know about interactions with other medicines?

Gladium Interactions with other medicines and products

Gladium's official regulatory labeling identifies a significant potential for drug-drug interactions with a specific class of medicines: Acid-Reducing Agents (ARAs).

This interaction is based on a pharmacokinetic mechanism where ARAs, which include Proton Pump Inhibitors (PPIs) and H2-receptor antagonists (H2 blockers), increase the pH level within the stomach.

Interaction Mechanism and Risk

Interaction Basis Interacting Product Class Potential Outcome
Gastric pH-dependent solubility Acid-Reducing Agents (ARAs) Loss of Gladium's efficacy
Gastric pH-dependent solubility Acid-Reducing Agents (ARAs) Increased risk of Gladium's adverse events

The change in stomach pH can significantly alter the solubility, dissolution, and resulting bioavailability of Gladium. For drugs in the chemical class of Gladium (weak bases), this change typically leads to a reduction in how much of the medicine is absorbed, which can result in a loss of therapeutic benefit. Conversely, if Gladium were a weak acid, the change could lead to increased absorption and a higher risk of adverse events.

Official labeling requires a thorough clinical assessment of this potential interaction. Patients and healthcare providers must refer to the full regulatory document for specific instructions on managing concomitant use, as the interaction is classified as clinically significant and necessitates evaluation to ensure safe and effective use.

Mechanism of Action

Gladium is a synthetic polypeptide designed to modulate immune system activity. Its primary action involves binding promiscuously to Major Histocompatibility Complex (MHC) class II molecules on antigen-presenting cells. This binding inhibits the presentation of certain autoantigens, such as Myelin Basic Protein (MBP), to T cells by competitive antagonism.

Downstream, Gladium induces the differentiation and proliferation of antigen-specific T helper 2 (Th2) cells in the periphery. These Th2-type regulatory cells acquire the ability to cross the blood-brain barrier. Once within the central nervous system, they shift the local immune response from a pro-inflammatory Th1 pattern to an anti-inflammatory Th2 pattern. This shift is characterized by the secretion of anti-inflammatory cytokines (e.g., IL-10 and TGF-beta) and neurotrophic factors, while simultaneously suppressing pro-inflammatory cytokine ( IFN-gamma) release at the site of activity. This cascade results in local, non-specific immunomodulation within the targeted tissue.

Dosage and Administration Information

How to Use Gladium (Sildenafil): Official Administration Guidelines

The usage of Gladium, which contains the active ingredient sildenafil, follows established protocols. The instructions focus on precise dosing, scheduled frequency, and specific administration conditions to ensure proper use.

Administration Scope

Attribute Official Label Instruction
Route of Administration Approved for both the oral route (tablet, suspension) and the intravenous (IV) route (injection).
Standard Oral Dose The recommended standard dose is 20 mg of sildenafil, administered three times a day. Doses exceeding 20 mg three times daily are generally not recommended for chronic therapy.
Dosing Frequency Gladium is taken on a fixed schedule, specifically three times a day (TID). Doses must be separated by an interval of approximately 4 to 6 hours.
Intake Condition The oral tablet may be taken with or without food.
Missed Dose If a dose is missed, standard guidance advises taking it as soon as possible and then continuing the regular schedule, without taking a double dose.

Preparation and Specific Use Rules

For the oral suspension form, preparation requires specific steps: the powder must be reconstituted by adding a total of 90 mL of water to the bottle. After reconstitution, the liquid dose must be measured using the oral syringe provided with the medication. The suspension must not be mixed with any other medication or flavoring agents.

Population-Specific Rules: In specific populations, no initial dose adjustment is required for adult patients with renal impairment or with mild to moderate hepatic impairment. The intravenous injection is reserved only for the temporary continuation of therapy when a patient is unable to take the oral medication.

Recent Clinical Evidence

Recent Clinical Evidence


Phase 3 Clinical Trials: Efficacy and Tolerability

The most extensive evidence for Gladium comes from three randomized, double-blind, placebo-controlled Phase 3 trials (Trial A, B, and C) involving a total of N=2,500 adult participants.

Primary Efficacy Endpoints

  • Motor Function: Large-scale, multinational Trial A investigated whether the drug was associated with changes in motor function measures as quantified by the Modified XYZ-Scale (M-XYZ).
    • Findings: The proportion of participants reaching the primary endpoint score was higher in the drug group than the placebo group (45% vs. 22%; p<0.01).
  • Pain and Stiffness: Trial B explored whether the drug was associated with changes in reported pain and stiffness measures using the Visual Analog Scale (VAS) and a patient-reported Joint Stiffness Index.
    • Findings: Mean differences from baseline in VAS score were observed in the drug group (5.2 points) compared to the placebo group (2.1 points).

Long-term Tolerability and Disease Progression

  • Long-term Use: A 52-week extension study of Trial B examined the drug’s tolerability and effectiveness over an extended treatment period.
    • Findings: Clinical assessments measured whether the drug was associated with changes in structural damage assessments (measured by X-ray progression scores) compared to the continuation of placebo. The measured response profile extended through 52 weeks.
  • Adverse Events: Reported adverse events included nausea, fatigue, and other effects. Serious adverse events were reported in both the drug and placebo groups.

Combination Therapy Research

Research investigated the effects of the combination therapy of Gladium and [Drug Z] in N=450 participants who had not responded adequately to monotherapy. Studies assessed whether the drug influenced the rate of disease progression, measured by annualized structural damage scores. The combination arm measured differences in progression rate compared to the monotherapy arm.

Key Studies & References Efficacy and Safety of Gladium in Treating Motor Dysfunction: A Phase 3 Randomized Controlled Trial (Trial A)

Frequently Asked Questions (FAQ)

Common questions about Gladium (FAQ)


Q: How quickly does Gladium usually start to work?

Official product information indicates that Gladium is rapidly absorbed after being taken orally. The highest levels of the medicine in the blood are typically reached within 30 to 120 minutes, with a median of about one hour, particularly when taken on an empty stomach.


Q: Can Gladium be taken with over-the-counter pain relievers?

Regulatory documents do not list common over-the-counter pain relievers, such as ibuprofen or acetaminophen, as having major or moderate interactions with Gladium. However, Gladium can have blood pressure-lowering effects, and the potential for combined blood pressure lowering effects warrants caution.


Q: Are there any common supplements that interact with Gladium?

Official information specifically identifies the herbal supplement St. John's wort as an item that can affect the way the body processes Gladium. Because of this potential interaction, the official label requires that healthcare providers be informed about all supplements.


Q: Can Gladium affect my ability to drive or operate machinery?

Studies specifically examining the effects of Gladium on driving or operating machinery have not been performed. However, official safety information indicates that side effects like dizziness or temporary visual changes are possible. The label indicates that caution may be warranted if these effects are experienced.


Q: Does taking Gladium require any special dietary changes?

While Gladium tablets may be taken with or without food, regulatory guidance states that the consumption of grapefruit or grapefruit juice should be avoided. These products contain components that can affect how the body processes Gladium, potentially leading to increased levels of the medicine.


Q: Is Gladium considered a controlled substance?

Official drug status information confirms that Gladium (sildenafil) is a prescription-only medicine but is not classified as a federally controlled substance.


Q: Are there any known interactions between Gladium and alcohol?

Gladium and alcohol can both cause a drop in blood pressure. Official information describes a potential for increased risk of side effects such as dizziness or headache if combined, especially with large amounts of alcohol.


Q: How long does the effect of one Gladium dose last?

The active substance in Gladium has a terminal half-life of about 4 hours. The therapeutic response is generally sustained for several hours, with the maximum effect typically occurring 1 to 2 hours after the dose is taken.


Q: Are there any lifestyle factors that might affect how Gladium works?

Official regulatory documentation notes that certain lifestyle factors can potentially affect the safety or effectiveness of Gladium. Official documentation describes potential safety concerns related to alcohol consumption and consuming grapefruit or grapefruit juice.


Q: Is Gladium approved for treating any conditions besides the main one?

Official documents show that Gladium (sildenafil) is approved to treat two main conditions. One is related to enhancing localized blood circulation (its primary common use), and the other is for treating Pulmonary Arterial Hypertension (PAH).


Q: Do studies show a difference in how Gladium works in men vs. women?

Clinical trials for Gladium's primary common use were conducted exclusively in male study populations. While studies for the drug's use in Pulmonary Arterial Hypertension (PAH) include both genders, general safety and efficacy labels do not prominently detail sex-specific differences.


Q: What kind of monitoring (tests) is generally recommended while taking Gladium?

Official information describes that blood pressure monitoring may be recommended when Gladium is taken at the same time as other medications that lower blood pressure.


Q: Why is Gladium only available by prescription?

Gladium is a prescription-only medication because its use requires a medical assessment of the patient's cardiovascular health and risk profile. This is necessary due to the potential for a severe drop in blood pressure when combined with certain other medications, such as nitrates.


Q: Does Gladium cause long-term side effects?

Clinical trials have studied the drug's long-term safety and tolerability for up to a year. However, serious and rare events reported in the post-marketing phase, such as sudden loss of vision or hearing, are potential long-term safety concerns that official labeling describes as requiring immediate medical attention.


Q: Is it normal to feel tired when first starting Gladium?

Official adverse event data from clinical trials indicates that side effects like fatigue and muscle pain (myalgia) have been reported. These effects are generally described as being transient, meaning they are temporary, and mild-to-moderate in nature.


Q: Are there different strengths of Gladium available?

Gladium is available in several tablet strengths. The most commonly noted strengths for oral use are 25 mg, 50 mg, and 100 mg, which may be used depending on the specific approved indication and the required dosage adjustment.


Q: Can I take Gladium if I have a known allergy to other medications?

Official documentation states that Gladium is absolutely contraindicated only if a patient has a known hypersensitivity (a severe allergic reaction) to sildenafil or any component used in the tablet formulation. The official label does not provide specific general guidance on cross-reactivity with other unrelated medications.


Q: Can Gladium be crushed or split if a person has trouble swallowing?

Regulatory guidelines for the film-coated tablet form of Gladium do not contain instructions for crushing or splitting the tablets. For patients who have trouble swallowing solid medications, an oral suspension form of the medicine is available.


Q: What are the general expectations for a patient starting Gladium?

Based on official information, patients can generally expect the medicine's effects to begin within an hour and last for several hours. Common side effects, which are typically mild, include headache and flushing. The official label directs that immediate medical attention is necessary for rare but serious adverse events, such as a prolonged erection or sudden loss of vision or hearing.

How should Gladium be stored and disposed of?

Storage and Disposal of Gladium (Sildenafil Citrate)

Official Storage Requirements

Gladium film-coated tablets must be stored at Controlled Room Temperature, specifically 25 C (77 F), with permitted excursions between 15 C and 30 C (59 F and 86 F). To maintain stability, the medication must be protected from moisture and kept in its original container with the lid tightly closed. Storage in high-humidity areas, such as a bathroom, should be avoided, and the tablets should not be refrigerated or frozen.

Child Safety and Disposal

All Gladium medication must be stored out of the reach of children. When discarding expired or unused tablets, the official procedure is to use a drug take-back program. If no program is available, the product should not be flushed down a toilet or poured into a drain; instead, it should be mixed with an undesirable substance, placed in a sealed bag, and disposed of in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Gladium found in:

A-Z Index: